Reneo Pharmaceuticals Inc

NASDAQ:RPHM   3:56:41 PM EDT
2.02
0.00 (0.00%)
7:29:03 PM EDT: $2.02 0.00 (0.00%)
Other Pre-Announcement

Reneo Pharmaceuticals Reports Third Quarter Results

Published: 11/08/2022 15:35 GMT
Reneo Pharmaceuticals Inc (RPHM) - Reneo Pharmaceuticals Reports Third Quarter 2022 Financial Results.
Qtrly Loss per Share $0.53.company Had About $116 Million in Cash, Cash Equivalents and Short-term Investments As of September 30, 2022.
Reneo Pharmaceuticals - Sees Completion of Enrollment in Pivotal Stride Study in Q1 of 2023; Topline Data in Q4 of 2023.
Reneo Pharmaceuticals - Update on Plans to Study Ren001 in Pmm Patients With Ndna Defects in First Quarter of 2023.
Q3 Earnings per Share View $-0.57 -- Refinitiv Ibes Data (analyst estimates).